future of glp 1 drugs 3 Ways GLP-1 Could Impact Your Hospital's GLP-1 Medications for Weight Loss:

Ask your health provider for guidance

GLP-1 Coverage and Cost Transparency for Members and Plans The GLP-1 boom illustrates how difficult it can be to predict and prepare for a sudden surge in utilization and costly claims, or the next shortage

Due to TMAO excretion in urine [56, 57], in chronic renal disease patients, TMAO elimination from the body fails, causing elevation of its plasma concentration [78]

Some now cover GLP-1s only with a diabetes diagnosis

56% also covered for weight loss Among those that cover GLP-1s, 77% follow their PBMs authorization criteria when the medications are prescribed to manage diabetes

The table below provides a glimpse into the evolving landscape of the GLP-1 class